FDA Inspection 717757 — Sagent Pharmaceuticals

Sagent Pharmaceuticals — FEI 3006167046

The FDA completed an inspection of Sagent Pharmaceuticals on March 11, 2011 in Schaumburg, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 11, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Schaumburg, IL (United States)